These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31330885)

  • 41. 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease.
    Li XH; Dai CF; Chen L; Zhou WT; Han HL; Dong ZF
    CNS Neurosci Ther; 2016 Jul; 22(7):617-24. PubMed ID: 27079181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice.
    Sridharan S; Mohankumar K; Jeepipalli SP; Sankaramourthy D; Ronsard L; Subramanian K; Thamilarasan M; Raja K; Chandra VK; Sadras SR
    Neurotoxicology; 2015 Dec; 51():172-83. PubMed ID: 26522450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice.
    Rozas G; Liste I; Guerra MJ; Labandeira-Garcia JL
    Neurosci Lett; 1998 Apr; 245(3):151-4. PubMed ID: 9605478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.
    Friedemann T; Ying Y; Wang W; Kramer ER; Schumacher U; Fei J; Schröder S
    Am J Chin Med; 2016; 44(5):907-25. PubMed ID: 27430912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson's Model.
    Liu Y; Jin W; Deng Z; Wang J; Zhang Q
    Mar Drugs; 2020 Aug; 18(9):. PubMed ID: 32842556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extract of Polygala tenuifolia, Angelica tenuissima, and Dimocarpus longan Reduces Behavioral Defect and Enhances Autophagy in Experimental Models of Parkinson's Disease.
    Li H; Kim J; Tran HNK; Lee CH; Hur J; Kim MC; Yang HO
    Neuromolecular Med; 2021 Sep; 23(3):428-443. PubMed ID: 33432492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration.
    Sakamula R; Yata T; Thong-Asa W
    Metab Brain Dis; 2022 Jun; 37(5):1465-1476. PubMed ID: 35353275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schisandra chinensis extract decreases chloroacetaldehyde production in rats and attenuates cyclophosphamide toxicity in liver, kidney and brain.
    Zhai J; Zhang F; Gao S; Chen L; Feng G; Yin J; Chen W
    J Ethnopharmacol; 2018 Jan; 210():223-231. PubMed ID: 28821392
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Chang HC; Liu KF; Teng CJ; Lai SC; Yang SE; Ching H; Wu CR
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
    Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L
    Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ginsenoside Rg1 Ameliorates Motor Function in an Animal Model of Parkinson's Disease.
    Jiang W; Wang Z; Jiang Y; Lu M; Li X
    Pharmacology; 2015; 96(1-2):25-31. PubMed ID: 26065578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse.
    Jeong EJ; Lee HK; Lee KY; Jeon BJ; Kim DH; Park JH; Song JH; Huh J; Lee JH; Sung SH
    J Ethnopharmacol; 2013 Mar; 146(1):347-54. PubMed ID: 23333311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyperi Rhizoma inhibits the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reduction in nigrostriatal dopaminergenic neurons in estrogen-deprived mice.
    Kim HG; Hong J; Huh Y; Park C; Hwang DS; Choi JH; Oh MS
    J Ethnopharmacol; 2013 Jun; 148(1):322-8. PubMed ID: 23639362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease.
    Kato H; Araki T; Imai Y; Takahashi A; Itoyama Y
    J Neurol Sci; 2003 Apr; 208(1-2):9-15. PubMed ID: 12639719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron.
    Wang YQ; Wang MY; Fu XR; Peng-Yu ; Gao GF; Fan YM; Duan XL; Zhao BL; Chang YZ; Shi ZH
    Free Radic Res; 2015; 49(9):1069-80. PubMed ID: 25968939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of chinonin in MPTP-induced C57BL/6 mouse model of Parkinson's disease.
    Feng G; Zhang Z; Bao Q; Zhang Z; Zhou L; Jiang J; Li S
    Biol Pharm Bull; 2014; 37(8):1301-7. PubMed ID: 24871044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Liu W; Jalewa J; Sharma M; Li G; Li L; Hölscher C
    Neuroscience; 2015 Sep; 303():42-50. PubMed ID: 26141845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.